Content area

Abstract

Abzug comments that the first effective prophylactic strategy against respiratory syncytial virus (RSV) has arrived: passive immunization with a high-titre intravenous immune globulin product, RSV-IGIV. RSV-IGIV is a promising first victory.

Details

Title
Assault against respiratory syncytial virus: Beginning of an era
Author
Abzug, Mark J
Pages
743-4
Publication year
1997
Publication date
Mar 15, 1997
Publisher
Elsevier Limited
ISSN
01406736
e-ISSN
1474547X
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1016/S0140-6736(05)60194-8
ProQuest document ID
199055448
Copyright
Copyright Lancet Ltd. Mar 15, 1997